211 related articles for article (PubMed ID: 14573861)
1. Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold.
Datta A; Stone MJ
Protein Sci; 2003 Nov; 12(11):2482-91. PubMed ID: 14573861
[TBL] [Abstract][Full Text] [Related]
2. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation.
Datta-Mannan A; Stone MJ
Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331
[TBL] [Abstract][Full Text] [Related]
3. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3.
Ye J; Kohli LL; Stone MJ
J Biol Chem; 2000 Sep; 275(35):27250-7. PubMed ID: 10859315
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
6. Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines.
Mayer KL; Stone MJ
Proteins; 2003 Feb; 50(2):184-91. PubMed ID: 12486712
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation.
Fernandez EJ; Wilken J; Thompson DA; Peiper SC; Lolis E
Biochemistry; 2000 Oct; 39(42):12837-44. PubMed ID: 11041848
[TBL] [Abstract][Full Text] [Related]
8. NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2.
Mayer KL; Stone MJ
Biochemistry; 2000 Jul; 39(29):8382-95. PubMed ID: 10913244
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
[TBL] [Abstract][Full Text] [Related]
10. Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding.
Crump MP; Spyracopoulos L; Lavigne P; Kim KS; Clark-lewis I; Sykes BD
Protein Sci; 1999 Oct; 8(10):2041-54. PubMed ID: 10548050
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of novel antagonists of the CCR3 receptor.
Warrior U; McKeegan EM; Rottinghaus SM; Garcia L; Traphagen L; Grayson G; Komater V; McNally T; Helfrich R; Harris RR; Bell RL; Burns DJ
J Biomol Screen; 2003 Jun; 8(3):324-31. PubMed ID: 12857386
[TBL] [Abstract][Full Text] [Related]
12. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
13. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.
Zhu JZ; Millard CJ; Ludeman JP; Simpson LS; Clayton DJ; Payne RJ; Widlanski TS; Stone MJ
Biochemistry; 2011 Mar; 50(9):1524-34. PubMed ID: 21235238
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.
Kitaura M; Suzuki N; Imai T; Takagi S; Suzuki R; Nakajima T; Hirai K; Nomiyama H; Yoshie O
J Biol Chem; 1999 Sep; 274(39):27975-80. PubMed ID: 10488147
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
17. The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b.
Martinelli R; Sabroe I; LaRosa G; Williams TJ; Pease JE
J Biol Chem; 2001 Nov; 276(46):42957-64. PubMed ID: 11559700
[TBL] [Abstract][Full Text] [Related]
18. Specificity determinants for chemokine recognition identified using eotaxin-MCP-1 chimeras.
Mayer MR; Parody TR; Datta-Mannan A; Stone MJ
FEBS Lett; 2004 Jul; 571(1-3):166-70. PubMed ID: 15280036
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor CCR3 function is highly dependent on local pH and ionic strength.
Dairaghi DJ; Oldham ER; Bacon KB; Schall TJ
J Biol Chem; 1997 Nov; 272(45):28206-9. PubMed ID: 9353270
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11/eotaxin-1.
Millard CJ; Ludeman JP; Canals M; Bridgford JL; Hinds MG; Clayton DJ; Christopoulos A; Payne RJ; Stone MJ
Structure; 2014 Nov; 22(11):1571-81. PubMed ID: 25450766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
